Pfizer vaccine protects children from a rare complication
Two doses of the Pfizer/BioNTech coronavirus vaccine have a high degree of protection against a rare serious illness in children, which is inflammation of the internal organs.
This is stated in Report of the US Centers for Disease Control and Prevention, reports The Jerusalem Post.
The vaccine is estimated to be 91% effective in preventing Multi-System Inflammatory Syndrome (MIS-C) in children. This inflammation can occur 2-6 weeks after mild or asymptomatic COVID.
This estimate is based on an analysis of data from 283 hospitalized patients aged 12-18 years in 24 children's hospitals in 20 states during the period from July to early December 2021.
The study says 38 patients with MIS-C in need of life support were not vaccinated.
Related Posts
About The Author
Elizabeth
Elizabeth Stone has been a reporter on the news desk since 2013. Before that she wrote about young adolescence and family dynamics for Styles and was the legal affairs correspondent for the Metro desk. Before joining The Quebec Telegram, Elizabeth Stone worked as a staff writer at the Village Voice and a freelancer for Newsday, The Wall Street Journal, GQ and Mirabella. To get in touch, contact me through my stone@qtelegram.com 1-800-268-7116